• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Blue Foundry Bancorp Names Elizabeth Varki Jobes, Esq. to Board of Directors

    1/5/23 5:07:32 PM ET
    $BLFY
    Banks
    Finance
    Get the next $BLFY alert in real time by email

    RUTHERFORD, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), announced today the appointment of Elizabeth Varki Jobes, Esq. as a Director, effective immediately.

    James D. Nesci, President and Chief Executive Officer stated, "We are excited to welcome Ms. Jobes to Blue Foundry's Board of Directors. Her years of combined legal and compliance experience leading large, global companies will bring additional perspective to our Board and will prove to be instrumental at Blue Foundry."

    Ms. Jobes serves as Senior Vice President and Global Chief Compliance Officer of Amryt Pharmaceuticals, a global commercial-stage pharmaceutical company, since 2020. Before joining Amryt, Jobes served as Senior Vice President and Chief Compliance Officer of North America at EMD Serono. Ms. Jobes also served in leadership roles at Spark Therapeutics, Auxilium Pharmaceutical, and Cephalon. Prior to her career in the pharmaceuticals industry, Jobes held various roles within Philadelphia's District Attorney's Office from 1991 to 2006.

    Ms. Jobes' service on several boards demonstrates her invaluable leadership skills. She currently serves on the board of Ampio Pharmaceuticals, a public company, as well as the board of a private biopharmaceutical company (Eyam Vaccines and Immunotherapeutics), and the board of a not-for-profit organization.

    Ms. Jobes is a member of the South Asian Bar Association and was a former board member of Women's Way. She received her law degree from Rutgers University School of Law and is licensed to practice in both New Jersey and Pennsylvania.

    Ms. Jobes commented, "I am eager to join Blue Foundry's innovative culture and dynamic leadership team. I look forward to leveraging my experience to build upon the Bank's exceptional reputation."

    About Blue Foundry Bancorp and Blue Foundry Bank

    Blue Foundry Bancorp is the holding company for Blue Foundry Bank, a place where things are made, purpose is formed, and ideas are crafted. Headquartered in Rutherford NJ, with presence in Bergen, Essex, Hudson, Morris, Passaic and Somerset counties, Blue Foundry Bank is a full-service, innovative bank serving the doers, movers, and shakers in our communities. We offer individuals and businesses alike the tailored products and services they need to build their futures. With a rich history dating back more than 145 years, Blue Foundry Bank has a longstanding commitment to its customers and communities. 

    Contacts:

    James D. Nesci 

    President and Chief Executive Officer

    bluefoundrybank.com

    [email protected] 

    201-972-8900



    Primary Logo

    Get the next $BLFY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BLFY

    DatePrice TargetRatingAnalyst
    5/17/2023$9.50Neutral
    Piper Sandler
    1/25/2023Buy → Neutral
    Compass Point
    8/30/2022$13.25Mkt Perform
    Keefe Bruyette
    More analyst ratings

    $BLFY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Blue Foundry Bancorp Reports Third Quarter 2025 Results

    RUTHERFORD, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), today reported a net loss of $1.9 million, or $0.10 per diluted common share, for the three months ended September 30, 2025, compared to net loss of $2.0 million, or $0.10 per diluted common share, for the three months ended June 30, 2025, and a net loss of $4.0 million, or $0.19 per diluted common share, for the three months ended September 30, 2024. James D. Nesci, President and Chief Executive Officer, commented, "During the third quarter, we experienced expansion in our net interest margin due to improvements in both yield on

    10/29/25 8:15:00 AM ET
    $BLFY
    Banks
    Finance

    Blue Foundry Bancorp Schedules Third Quarter 2025 Earnings Conference Call

    RUTHERFORD, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank, announced that on the morning of Wednesday, October 29, 2025 it will release financial results for the quarter ended September 30, 2025. A copy of the earnings release will be available on the Company's website, https://ir.bluefoundrybank.com/, in the "News" section and on the SEC's website, https://www.sec.gov/. Representatives of the Company will hold a conference call for investors and analysts on Wednesday, October 29, 2025 at 11:00AM (ET) to discuss Third Quarter 2025 Earnings. Blue Foundry Bancorp will address live questions from analysts

    10/8/25 8:15:00 AM ET
    $BLFY
    Banks
    Finance

    Blue Foundry Bancorp Reports Second Quarter 2025 Results

    RUTHERFORD, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), today reported a net loss of $2.0 million, or $0.10 per diluted common share, for the three months ended June 30, 2025, compared to net loss of $2.7 million, or $0.13 per diluted common share, for the three months ended March 31, 2025, and a net loss of $2.3 million, or $0.11 per diluted common share, for the three months ended June 30, 2024. James D. Nesci, President and Chief Executive Officer, commented, "We are encouraged by the continued improvement experienced this quarter, highlighted by net interest margin expansion, stable

    7/30/25 8:15:00 AM ET
    $BLFY
    Banks
    Finance

    $BLFY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Risk Officer Owes Keith covered exercise/tax liability with 1,023 shares, decreasing direct ownership by 7% to 14,477 units (SEC Form 4)

    4 - Blue Foundry Bancorp (0001846017) (Issuer)

    9/22/25 5:06:14 PM ET
    $BLFY
    Banks
    Finance

    Director Kinzler Patrick H. bought $12,760 worth of shares (1,500 units at $8.51), increasing direct ownership by 2% to 77,911 units (SEC Form 4)

    4 - Blue Foundry Bancorp (0001846017) (Issuer)

    8/6/25 5:17:45 PM ET
    $BLFY
    Banks
    Finance

    Director Kinzler Patrick H. bought $21,026 worth of shares (2,500 units at $8.41), increasing direct ownership by 3% to 76,411 units (SEC Form 4)

    4 - Blue Foundry Bancorp (0001846017) (Issuer)

    8/4/25 4:28:02 PM ET
    $BLFY
    Banks
    Finance

    $BLFY
    SEC Filings

    View All

    Blue Foundry Bancorp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Blue Foundry Bancorp (0001846017) (Filer)

    10/29/25 10:12:01 AM ET
    $BLFY
    Banks
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Blue Foundry Bancorp

    SCHEDULE 13G/A - Blue Foundry Bancorp (0001846017) (Subject)

    9/10/25 12:53:03 PM ET
    $BLFY
    Banks
    Finance

    SEC Form 10-Q filed by Blue Foundry Bancorp

    10-Q - Blue Foundry Bancorp (0001846017) (Filer)

    8/12/25 3:43:55 PM ET
    $BLFY
    Banks
    Finance

    $BLFY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kinzler Patrick H. bought $12,760 worth of shares (1,500 units at $8.51), increasing direct ownership by 2% to 77,911 units (SEC Form 4)

    4 - Blue Foundry Bancorp (0001846017) (Issuer)

    8/6/25 5:17:45 PM ET
    $BLFY
    Banks
    Finance

    Director Kinzler Patrick H. bought $21,026 worth of shares (2,500 units at $8.41), increasing direct ownership by 3% to 76,411 units (SEC Form 4)

    4 - Blue Foundry Bancorp (0001846017) (Issuer)

    8/4/25 4:28:02 PM ET
    $BLFY
    Banks
    Finance

    EVP and Chief Tech Officer Malkiman Aleksandr bought $33,948 worth of shares (4,000 units at $8.49), increasing direct ownership by 22% to 22,100 units (SEC Form 4)

    4 - Blue Foundry Bancorp (0001846017) (Issuer)

    8/4/25 4:26:50 PM ET
    $BLFY
    Banks
    Finance

    $BLFY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler initiated coverage on Blue Foundry Bancorp with a new price target

    Piper Sandler initiated coverage of Blue Foundry Bancorp with a rating of Neutral and set a new price target of $9.50

    5/17/23 7:28:36 AM ET
    $BLFY
    Banks
    Finance

    Blue Foundry Bancorp downgraded by Compass Point

    Compass Point downgraded Blue Foundry Bancorp from Buy to Neutral

    1/25/23 2:52:48 PM ET
    $BLFY
    Banks
    Finance

    Keefe Bruyette initiated coverage on Blue Foundry Bancorp with a new price target

    Keefe Bruyette initiated coverage of Blue Foundry Bancorp with a rating of Mkt Perform and set a new price target of $13.25

    8/30/22 7:16:26 AM ET
    $BLFY
    Banks
    Finance

    $BLFY
    Leadership Updates

    Live Leadership Updates

    View All

    Seasoned Leader Brings Decades of Legal, Administrative and Corporate Expertise to the Board

    RUTHERFORD, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), announced today the appointment of John F. Kuntz, Esq. as a Director of both the Company and its subsidiary, Blue Foundry Bank, effective immediately. Kenneth Grimbilas, Chairman, stated, "We are very pleased to have Mr. Kuntz join Blue Foundry's Board of Directors. His extensive knowledge and experience in financial, legal and operational matters will provide additional perspective and depth to the organization. His experience with charitable foundations will also prove to be instrumental at Blue Foundry." Mr. Kuntz most recently served as Senior Executive Vice President and Chief Adm

    7/23/24 5:52:09 PM ET
    $BLFY
    Banks
    Finance

    Blue Foundry Bancorp Names Elizabeth Varki Jobes, Esq. to Board of Directors

    RUTHERFORD, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), announced today the appointment of Elizabeth Varki Jobes, Esq. as a Director, effective immediately. James D. Nesci, President and Chief Executive Officer stated, "We are excited to welcome Ms. Jobes to Blue Foundry's Board of Directors. Her years of combined legal and compliance experience leading large, global companies will bring additional perspective to our Board and will prove to be instrumental at Blue Foundry." Ms. Jobes serves as Senior Vice President and Global Chief Compliance Officer of Amryt Pharmaceuticals, a global commercial-stage pharmaceutical company, since 2020. Bef

    1/5/23 5:07:32 PM ET
    $BLFY
    Banks
    Finance

    $BLFY
    Financials

    Live finance-specific insights

    View All

    Blue Foundry Bancorp Reports Third Quarter 2025 Results

    RUTHERFORD, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), today reported a net loss of $1.9 million, or $0.10 per diluted common share, for the three months ended September 30, 2025, compared to net loss of $2.0 million, or $0.10 per diluted common share, for the three months ended June 30, 2025, and a net loss of $4.0 million, or $0.19 per diluted common share, for the three months ended September 30, 2024. James D. Nesci, President and Chief Executive Officer, commented, "During the third quarter, we experienced expansion in our net interest margin due to improvements in both yield on

    10/29/25 8:15:00 AM ET
    $BLFY
    Banks
    Finance

    Blue Foundry Bancorp Schedules Third Quarter 2025 Earnings Conference Call

    RUTHERFORD, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank, announced that on the morning of Wednesday, October 29, 2025 it will release financial results for the quarter ended September 30, 2025. A copy of the earnings release will be available on the Company's website, https://ir.bluefoundrybank.com/, in the "News" section and on the SEC's website, https://www.sec.gov/. Representatives of the Company will hold a conference call for investors and analysts on Wednesday, October 29, 2025 at 11:00AM (ET) to discuss Third Quarter 2025 Earnings. Blue Foundry Bancorp will address live questions from analysts

    10/8/25 8:15:00 AM ET
    $BLFY
    Banks
    Finance

    Blue Foundry Bancorp Reports Second Quarter 2025 Results

    RUTHERFORD, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), today reported a net loss of $2.0 million, or $0.10 per diluted common share, for the three months ended June 30, 2025, compared to net loss of $2.7 million, or $0.13 per diluted common share, for the three months ended March 31, 2025, and a net loss of $2.3 million, or $0.11 per diluted common share, for the three months ended June 30, 2024. James D. Nesci, President and Chief Executive Officer, commented, "We are encouraged by the continued improvement experienced this quarter, highlighted by net interest margin expansion, stable

    7/30/25 8:15:00 AM ET
    $BLFY
    Banks
    Finance

    $BLFY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Blue Foundry Bancorp

    SC 13G/A - Blue Foundry Bancorp (0001846017) (Subject)

    11/14/24 1:28:35 PM ET
    $BLFY
    Banks
    Finance

    SEC Form SC 13G/A filed by Blue Foundry Bancorp (Amendment)

    SC 13G/A - Blue Foundry Bancorp (0001846017) (Subject)

    2/14/24 10:04:41 AM ET
    $BLFY
    Banks
    Finance

    SEC Form SC 13G/A filed by Blue Foundry Bancorp (Amendment)

    SC 13G/A - Blue Foundry Bancorp (0001846017) (Subject)

    2/14/24 8:00:10 AM ET
    $BLFY
    Banks
    Finance